Introduction: Aberrant DNA methylation is frequently observed in colorectal cancer (CRC), but the underlying mechanisms are poorly understood. Ten-Eleven Translocation (TET) dioxygenases and DNA repair enzyme Thymine DNA Glycosylase (TDG) are involved in active DNA demethylation by generating and removing, respectively, novel oxidized cytosine species. Mutations of TET1 and TDG, and alterations of the levels of oxidized cytosine species have been identified in human CRC cases, but the biological significance of the TET-TDG demethylation axis in intestinal tumorigenesis is unclear. Material and Methods: We generated Apc Min mice with additional inactivation of Tet1 and/or Tdg, and characterized the methylome and transcriptome of intestinal adenomas by DREAM and RNA sequencing, respectively. Results: Tet1-and/or Tdg-deficient Apc Min mice show enhanced intestinal tumorigenesis in comparison to wild type Tet1 and Tdg Apc Min mice. Specifically, Tet1 and/or Tdg-deficient Apc Min adenomas manifested increased size or features of erosion and stroma activation. Methylome analysis revealed progressive loss of global DNA hypomethylation in colonic adenomas from Tet1-and Tdgdeficient Apc Min mice, and hypermethylation of CpG islands in Tet1-deficient Apc Min mice. In addition, RNA sequencing showed upregulation of genes in inflammatory and immune response pathways in Tet1-and Tdg-mutant colonic adenomas compared to control Apc Min adenomas. Conclusions: Taken together, these findings demonstrate the important role of active DNA demethylation mediated by TET-TDG in reducing intestinal tumor formation, by modulating the epigenome and inflammatory/immune responses. This study highlights a novel mechanism of epigenetic deregulation during intestinal tumorigenesis with diagnostic, therapeutic and prognostic implications.
Introduction
Colorectal cancer is the second leading cause of death from cancer in Western countries. Every year, approximately 140,000 new cases are diagnosed in U.S.A. and approximately 50,000 deaths occur (1) . It is reasonable to assume that successful control of this disease, via appropriate preventive, interventional and therapeutic strategies, will depend on the precise characterization of its molecular basis. Converging studies from different disciplines revealed that colorectal cancer, like many other epithelial malignancies, is characterized by multi-step carcinogenesis. In particular, studies by Drs.
Fearon and Vogelstein and Dr. Feinberg and colleagues demonstrated that several genetic and epigenetic alterations accumulate in cancer cells at critical genes that control rate-limiting steps of cell proliferation, differentiation and death (2, 3) . This has led to the hypothesis that some discrete genetic and epigenetic changes accompany the morphological transitions from normal colonic cells to a benign tumor (adenoma), to a malignant cancer (carcinoma).
Among the known genetic alterations in colorectal cancer development are inactivating mutations of the tumor suppressor genes APC, SMAD2-4 and TP53, and activating mutations of the oncogene KRAS. In addition, several epigenetic changes have been described, involving DNA methylation, chromatin modification and remodeling, and microRNA expression. Focusing our attention only on DNA-based epigenetic alterations, we can recognize: genome-wide DNA hypomethylation, particularly evident at satellite sequences; DNA hypermethylation and silencing of promoters of tumor suppressor genes and other CpG-rich sequences; and loss of imprinting marks discriminating the paternal and maternal alleles. Simultaneous hypermethylation of multiple CpG islands, the so called CpG island methylator phenotype (CIMP), is particularly evident in a fraction of colorectal tumors (4) . While some hypermethylation events are linked to aging (5) , it is clear that even after correcting for age, consistent hypermethylation of clusters of CpG islands is found in a subset of tumors. In fact, the existence of CIMP is probably the best evidence of epigenetic instability occurring in tumors (4) . Gene silencing by CIMP represents a powerful pathogenetic mechanisms because it can achieve inactivation of multiple tumor suppressor genes at once. CIMP has been recently described by the TCGA in other tumors, including gliomas and breast cancers. The molecular basis of CIMP in CRC is unknown. It is possible that CIMP reflects environmental or dietary exposure to epimutagens. It is also possible that CIMP originates from an imbalance of methylating activities and demethylating activities that normally protect CpG islands from methylation (4) .
Ten-Eleven Translocation (TET) family dioxygenases play a crucial role in active DNA demethylation by oxidizing 5-methylcytosine to 5-hydroxymethylcytosine (5hmC) and converting 5hmC to 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) (6) (7) (8) (9) (10) . Our data indicate that, through its CXXC domain, TET1 binds preferentially to hypomethylated CpG islands and maintains their hypomethylated status by removing and preventing the spreading of aberrant DNA methylation (11) . Hypothetically, loss of TET1 function might lead to the hypermethylator phenotype seen in CIMP. Low levels of 5hmC suggest an involvement of TET enzymes in CRC tumorigenesis (12, 13) .
In addition, we and others recently identified the base excision repair enzyme TDG as a critical effector of DNA demethylation downstream of TET enzymes, through the removal of 5fC, 5caC and 5-hydroxymethyluracil (5hmU), a deamination product of 5hmC (14) (15) (16) (17) (18) (19) . We also found that the expression of TDG is frequently reduced in CRC cell lines, and that TDG acts as an important tumor suppressor in the pathogenesis of a subset of intestinal tumors (20) . In addition, inactivation of TDG is associated with increased methylation (21) . Thus, loss of TDG could also result in CIMP or other epigenomic changes in CRC tumorigenesis.
Here, to functionally study the role of TET1 and TDG in epigenome modulation and CRC formation, we crossed mice bearing the Tet1knock-out allele and/or the dominant-negative, glycosylase-dead Tdg N151A allele with Apc-Min (Multiple Intestinal Neoplasia) mice, predisposed to colorectal neoplasia (in particular, we used the Fox Chase Cancer Center variant, characterized by high incidence of colonic lesions) (22, 23) . The results revealed a complex role of TET1 and TDG in modulating methylation patterns and gene expression, and revealed a tumor suppressive role via inhibition of inflammatory and immune response pathways.
Materials and Methods

Experimental animals
To generate F1 double heterozygotes (Tet1 +/-Apc Min/+ and Tet1 +/-Tdg N151A/+ ) mice, Tet1 +/-(24)(from The Jackson Laboratory) and Apc Min-FCCC (22) , were mated with Tdg N151A/+ mice (16) . F1 Tet1 +/-Apc Min/+ and Tet1 +/-Tdg N151A/+ were crossed to generate 90 F2 mice divided into the following fourgenotype groups: Tet1 -/-Tdg +/+ Apc Min/+ (n=7); Tet1 +/-Tdg N151A/+ Apc Min/+ (n=21); Tet1 +/+ Tdg N151A/+ Apc Min/+ (n=33); and Tet1 +/+ Tdg +/+ Apc Min/+ (n=29). All the strains used in this study have a C57BL/6 genetic background. The Institutional Animal Care and Use Committee of the Fox Chase Cancer Center approved animal protocols and all the procedures of mouse handling.
Histopathology and tumor load analyses
All the animals were monitored weekly for rectal prolapse and/or bleeding and sacrificed at 150-160 days. At the time of sacrifice, the small intestine, cecum, colorectum and other various tissues (including kidney, liver and spleen) were collected and inspected. Proximal, middle, and distal small intestine and colorectum were embedded in paraffin, and sections were stained with hematoxylin/eosin for histopathological analysis according to standard procedures. Small intestinal and colorectal adenomas were counted, evaluated for hemorrhagic features and measured with a ruler.
In addition, colonic adenomas were also collected for molecular analysis and histopathology. A 
Genome-wide methylation analysis
Genomic DNA was extracted from colonic adenomas and normal mucosa by Gentra Puregene Tissue Kit (Qiagen) according to manufacturer's instructions. Genome-wide methylation analysis was performed on genomic DNA prepared from 12 colonic adenomas (3 mice for each of the four genotype-groups) and normal colonic mucosa from 6 C57BL/6 mice by standard procedures.
Methylation levels were evaluated by Digital Restriction Enzyme Analysis of Methylation
(DREAM), as previously reported (25) . Briefly, methylation at specific CpG sites throughout the genome was evaluated by creating specific signatures at unmethylated and methylated CpG sites by sequential digests of genomic DNA with restriction endonucleases SmaI and XmaI, respectively. The restriction fragments with distinct signatures, 5′-GGG at unmethylated sites or 5′-CCGGG at methylated sites, were analyzed by next generation sequencing. Sequencing reads were mapped to the restriction sites in the reference genome, and signatures corresponding to methylation status of individual DNA molecules were resolved (26) . Methylation ratios for each individual CCCGGG site were calculated as a proportion of methylated counts to the sum of unmethylated and methylated counts. Differences in methylation were evaluated by comparing the level of methylation in each genotype-group and the level of methylation in normal colonic mucosa from C57BL/6 mice.
Analysis of DNA Methylation by Bisulfite Modification Sequencing
Bisulfite sequencing analysis was conducted to validate the difference in DNA methylation detected at the Dirc2 and Calb1 genes by DREAM and to investigate the DNA methylation of Apc promoter. 
RNA sequencing
A gene expression analysis by RNA-seq was conducted in triplicate per each genotype-group on the samples described previously in genome-wide methylation section. Briefly, RNA was isolated using 
Results
Adenoma multiplicity and characteristics in Tet1 and/or Tdg Apc Min mutant mice
To investigate the biological significance of the TET-TDG demethylation axis in intestinal tumorigenesis, we crossed Tet1 knockout and/or mice bearing the dominant-negative Tdg N151A allele with Apc Min (Multiple Intestinal Neoplasia) mice, predisposed to intestinal adenomas (with a rare occurrence of cancers) and resembling the human familial adenomatous polyposis (FAP) condition (27) . In particular, we used the Apc Min Fox Chase Cancer Center variant characterized by high incidence of colonic adenomas (22) . We studied a total of 90 mice with 4 genotypes:
Tet1 -/-Apc Min/+ ; Tet1 +/-Tdg N151A/+ Apc Min/+ ; Tdg N151A/+ Apc Min/+ and Tet1 +/+ Tdg +/+ ("wild type") Apc Min/+ . We first investigated whether Tet1 and /or Tdg defects modify tumor load (tumor multiplicity and size) in Apc Min background. Through a detailed inspection of the gastrointestinal tract, we found that Tet1 -/knockout and Tet1 +/-Tdg N151A/+ double heterozygotes exhibited an increased number of large colonic adenomas (> 3-7mm) compared with "wild type" Apc Min/+ mice ( Fig. 1A-D ).
We also found that a fraction of Tdg N151A/+ single heterozygous mice showed a predisposition to develop an increased number of intestinal adenomas (>30), mostly in the small intestine. This phenotype was not observed in Tet1 -/homozygotes, Tet1 +/-Tdg N151A/+ double heterozygotes or "wild type"Apc Min/+ mice ( Fig. 1E-F ).
Remarkably, a statistically significant increase of congested, hemorrhagic adenomas was observed in Tet1 -/homozygotes (p-value =0.0044) and Tet1 +/-Tdg N151A/+ double heterozygotes (p-value =0.0008) compared with "wild type" Apc Min/+ mice ( Fig. 1G-H) . Of note, the hemorrhagic adenomas in Tet1 -/homozygotes and Tet1 +/-Tdg N151A/+ double heterozygotes mice were limited to the colon and were rarely detected in "wild type"Apc Min/+ mice. Histopathological analysis of hemorrhagic adenomas from Tet1 -/homozygotes and Tet1 +/-Tdg N151A/+ double heterozygotes revealed features of invasion compared with "wild type"Apc Min/+ mice ( Fig. 1I-J) . Incidentally, no other tumors outside the digestive tract and no significant differences in survival were observed in Tet1 and/or Tdg deficient mice compared with "wild type"Apc Min/+ mice.
These observations indicate that both Tdg and Tet1 act as tumor suppressor genes in the intestine, affecting tumor size (Tet1) or multiplicity (Tdg). In addition, homozygous or heterozygous Tet1 mutations enhance intestinal tumorigenesis in the Apc Min/+ background by causing hemorrhagic adenomas with features of invasion (incipient conversion to malignancy).
Genome-wide DNA methylation analysis
The higher tumor load observed in Tet1 and Tdg mutant compared with "wild type"Apc Min/+ mice suggests that Tet1 and Tdg inactivation may have an impact on the intestinal tumorigenesis by an aberrant modulation of the epigenome, due their crucial role in active DNA demethylation. Our goal was to identify the epigenomic changes associated with Tet1 and Tdg defects in the context of Apc Min/+ mutation. To this purpose, we conducted a genome-wide DNA methylation analysis by digital restriction enzyme analysis of methylation (DREAM) (26) , which allows for identification of differentially methylated sites in CpG islands (CGI) and non-CpG islands (NCGI) at high resolution (it interrogates approximately 25K CpG sites in the murine genome). DREAM analysis was conducted on triplicate adenomas from mice within the four genotype groups, and on triplicate samples of colonic mucosa from C57BL6 mice.
We also investigated the differences in DNA methylation between Tet1 -/-, Tdg N151A/+ , Tet1 +/-Tdg N151A/+ and "wild type" Apc Min/+ adenomas more systematically by analyzing CGI and NCGI sites separately.
Compared to normal colonic mucosa, a global hypomethylation at NCGIs was detected in Apc Min/+ adenomas and corresponds to the genome-wide hypomethylation reported in human colonic adenomas as one of the earliest manifestations of multistep tumorigenesis in the colon (28-30)( Fig.   2A ). Remarkably, this global hypomethylation was progressively reduced in Tdg N151A/+ , Tet1 +/-Tdg N151A/+ and Tet1 -/adenomas ( Fig. 2A) , which indicates a shift towards increased methylation levels in the absence of a functional TET-TDG axis. Previous DNA methylation analysis of Apc Min tumors showed that these do not have much CpG island hypermethylation or CIMP (31) .
Interestingly, we found that only Tet1 -/adenomas showed elevated methylation at many CGI sites ( Fig. 2B) , which resembles the CpG island methylator phenotype (CIMP) in humans. No microsatellite instability (MSI), a phenotype associated with CIMP in human colorectal cancers, was detected in Tet1 deficient colonic adenomas (data not shown). Overall, a shift towards increased methylation was detected when Tet1 and Tdg mutant adenomas were compared to "wild type" Apc-Min adenomas (Fig. 2C ).
Next, we confirmed the methylation differences by bisulfite sequencing for two selected genes, Sema5b and Calb2, which were hypermethylated in Tet1 -/colonic adenomas at CGI and NCGI sites, respectively. We investigated the genomic DNA extracted from 3 Tet1 -/and 3 Apc Min/+ adenomas belonging to 6 different mice. 47 and 12 CpG sites were analyzed for Sema5b and Calb2, respectively. Analysis of these CpG sites confirmed hypermethylation in all the 3 Tet1 -/adenomas. Fig. 2D shows an overview of the significant increase in methylation at CpG sites for Sema5b (pvalue =2.89E-64) and Calb2 (p-value =2.95E-15) in the 3 Tet1 -/samples analyzed compared to "wild type" Apc Min/+ samples.
Genome-wide transcriptomic analysis
To clarify the role of Tet1 and Tdg in colorectal tumorigenesis and evaluate the impact of the methylation changes observed in Tet1 and Tdg-deficient adenomas on gene expression, we conducted a genome-wide transcriptomic analysis on Tet1 -/-, Tet1 +/-Tdg N151A/+ , Tdg N151A and Apc Min/+ adenomas.
Using a FDR cutoff of 5%, a total of 224 genes were found differentially expressed between the three mutant genotype-groups and the Apc Min/+ control group. Gene ontology analysis conducted on the 224 differentially expressed genes revealed an enrichment of inflammation, innate immunity, interferon signaling and antimicrobial response processes (Fig. 3) . A comparative analysis between each mutant genotype-group and Apc Min/+ control group identified 88, 74 and 123 genes differentially expressed in Tet1 -/-, Tet1 +/-Tdg N151A/+ , Tdg N151A/+ adenomas, respectively. We observed that 10 genes were shared among the three mutant genotype-groups, including calcium-and zinc-binding proteins (S100A8 and S100A9) implicated in differentiation of stromal myeloid cells (neutrophils and macrophages) and cytokine production (Exp. Med. 205 (10) : 2235-49), hormones (Retnlb and Retnlg) and an antimicrobial peptide (Defb45) involved in myeloid dendritic cell chemotaxis and antimicrobial response, respectively (Fig. 3a) . We also compared the differentially expressed genes between Tet1 -/and Tdg N151A/+ , Tet1 +/-Tdg N151A/+ and Tdg N151A/+ and Tet1 -/and Tet1 +/-Tdg N151A/+ genotype-groups. GO analysis of the genes shared only between Tet1 -/and Tdg N151A/+ (n=10), Tdg N151A/+ and Tet1 +/-Tdg N151A/+ (n=26) revealed that they were mostly immunoglobulins (Ighg1, Ighg2b, Igkv6-15 and Igkv1-117) and chemokines or their receptors (Cxlc2, Ccl3, Nos2, Cxcl3, Osm, Csf3, Il1r2, Chi3l3 and Arg1), respectively. No enrichment of biological processes was detected by GO analysis of the five genes (Snhg11, Mptx1, Aldh1a3, AI747448 and Adh1) in common between Tet1 -/and Tet1 +/-Tdg N151A/+ genotype-groups.
We also identified genes specifically expressed in each mutant genotype-group. In particular, 77 genes differentially expressed only in Tdg N151A/+ adenomas were mainly interleukins (Il1b, Il1a, Il1f9
and Il18rap), chemokines (Chi3l1, Ccrl2, Ccl4, Ccr1, Clca2, Cxcr2, Clec4e, Clec4d and Irg1) and immunoglobulins (Ighg2c, Ighv5-6, Ighv1-19, Ighv1-81, Igkv10-96, Igkv14-111 and Igkv1-135). Few genes belonging to the TRIM family proteins (Trim10, Trim15, Trim29) induced by the interferons were found also specifically expressed in Tdg N151A/+ adenomas. Conversely, most of the 63 genes differentially expressed in Tet1 -/knockouts mice are involved in interferon signaling (Oasl1, Oasl2, Oas3, Oas1a, Itln1, Itih5, Isg15, Ifit1, Ifit3, Ifit44, Trim30a, Rtp4 and Rsad2), major histocompatility complex (H2-Q5, H2-Q6, H2-Q7, H2-Aa, H2-Ab1, H2-Eb1) and the antimicrobial defense response (Defa3, Defa21, Defa22, Defa24 and Liz1). No cytokines and few immunoglobulins (Igkc, Iglv1 and Iglc2) were found specifically expressed in Tet1 -/knockouts mice. None of the 33 genes with specific expression in Tet1 +/-Tdg N151A/+ adenomas showed an enrichment of cytokines, interferon signaling or antimicrobial defense genes or other biological processes, except the presence of few immunoglobulins (Ighv9-1, Igkv3-2, Igkv4-53, Igkv4-68 and Igkv5-39).
Importantly, GO analysis also revealed a distinct gene expression profiles in Tet1 -/knockouts and
Tdg N151A/+ single heterozygotes mice. In particular, Tet1 -/knockouts mice showed a deregulation of interferon signaling and antimicrobial defense response, Tdg N151A/+ single heterozygotes mice an upregulation of inflammatory response. Moreover, we also observed that three mutant genotypegroups exhibited a similar over-expression profile, characterized by the upregulation of genes implicated in immune response.
Next, using pathway analysis we confirmed that the gene expression changes associated with Tet1 and /or Tdg defects were involved in inflammatory response and immunological disease. We also found diseases/bio functions specifically associated with each mutant genotype-group. In particular, antimicrobial response, endocrine system disorders and gastrointestinal diseases were found in Tet1 -/knockouts, dermatological disease and conditions in Tet1 +/-Tdg N151A/+ double heterozygotes and skeletal and muscular disorders in Tdg N151A/+ single heterozygotes. Moreover, connective tissue disorders and inflammatory disease were in common among Tet1 +/-Tdg N151A/+ double and Tdg N151A/+ single heterozygotes (Fig. 3) Finally, we validated eight selected differentially expressed genes (Mmp9, Retnlg, Retnlb, Aldh1a3, Ccl4, Mptx1, Sprr2h and Chil3) in the three mutant genotype groups using quantitative RT-PCR ( Fig.   3C and data not shown).
Histopathology
We conducted histopathological analysis to identify morphological correlates of the activation of immune response and inflammatory pathways. This analysis revealed increased surface erosion, stroma activation (desmoplasia) and inflammation in adenomas from Tet1 -/-, Tet1 +/-Tdg N151A/+ double heterozygous and Tdg N151A/+ mice, in comparison with "wild type" Apc Min/+ mice (Fig. 4A ). In addition, immunohistochemical staining with the f4/80 antibody revealed that Tet1-and/or Tdgmutant adenomas show an increased infiltration of macrophages in the stroma surrounding the adenomatous crypts, but not morphologically normal crypts (Fig. 4B ). No differences in T lymphocyte infiltration (as detected by CD3 staining) were found among adenomas of the four genotypes (data not shown).
Identification of a Tet1-and Tdg-related inflammatory signature; significance in human CRC
We conducted an unsupervised hierarchical clustering analysis for RNA expression levels for differentially expressed genes. Three samples (A34, B3 and C58) with Tet1 and/or Tdg defects clustered together and identified a list of 169 highly divergent, inflammatory genes (Fig. 5A) .
Remarkably, A34, B3 and C58 samples shared the upregulation of 75 genes mostly implicated in inflammation and innate immunity. Specifically, most of the 75 genes were interleukins (Il-11 and Il-1a), chemokines (Cxcl2, Cxcl3, Ccl4 and Ccl3), cytokine receptors (Il1-r2 and Cxcr2), lectins (Clec4e, Clec4d), receptors (Csf3r, Fpr1 and Fpr2), calcium-and zinc-binding protein (S100A8 and S100A9), hormone (Retnlg) expressed mainly by macrophages and other myeloid cells. Importantly, the corresponding human 135-gene signature separates the colon adenocarcinoma (COAD) TCGA samples in four clusters, that align strongly with their microsatellite stable (MSS/CIN) or unstable status (MSI/MIN)(p<0.0001) (Fig. 5B ). Whereas cluster 1 has mixed MSI/MSS status and cluster 3 corresponds to MSI cases, clusters 2 and 4 which are classified as MSS/CIN, display low and high inflammation gene expression signature, respectively (Fig. 5B ). Importantly, cluster 4 (high inflammatory signature, "hot") has low TET1 expression and vice versa cluster 2 (low inflammatory signature, "cold") has high TET1 expression. TDG expression did not vary across the four clusters, with the caveat that we are not measuring its activity. This suggests that the (epi)genetic program set forth by TET1-TDG suppresses inflammation; and its alterations in human CRC are strongly linked to, and help stratify, the intrinsic features of CIN.
Discussion
In this article, we show that both TET1 and TDG act as tumor suppressors in colorectal tumorigenesis, by affecting the number (TDG) or the size (TET1) of colonic adenomas. In addition, TET1 is involved in progression to malignancy, because colonic adenomas from Tet1 -/and Tet1 +/-Tdg N151A/+ mice show congestive/hemorrhagic appearance, corresponding to morphological features of invasion and incipient malignancy.
The tumor suppressive function of TET1 and TDG is likely linked to their role in active DNA demethylation, as they had a similar impact on epigenome of murine adenomas in comparison to "wild type" Apc-Min ademonas. However, only Tet1 inactivation was associated with a CIMP-like phenotype.
Analysis of gene expression revealed transcriptional activation of the inflammatory and immune
response pathways, which was confirmed by increased morphological features of inflammation in Tet1-and Tdg-mutant colonic adenomas. Previously, TET2 was shown to play a role in inflammation (32) , and acute TDG knockdown (21) led to overexpression of genes belonging to inflammatory response senescence-associated secretory phenotype (SASP) (33) (34) (35) . However, here we show that induction of inflammation associated with TET1/TDG inactivation is linked to CRC induction and progression.
Interestingly, the TET1/TDG inflammatory signature could separate TCGA COAD tumors based on their chromosomal instability status, which warrants further investigation. Recently, two types of aneuploidy have been described in a pan-cancer TCGA analysis: focal somatic copy number alterations (SCNA) (less than half of a chromosome arm) and arm-/chromosome-level SCNA, the latter associated with markers of immune evasion (36) . It will be interesting to compare immune signature scores, and focal or arm/chromosome SCNA levels (as described in (36) ) between CIN2-4 sample groups, to explore whether these types of aneuploidy preferentially segregate with hot or cold CIN, i.e. with low or high TET1 expression.
Taken together, the findings reported here suggest an important role of active DNA demethylation mediated by TET-TDG in epigenome modulation during CRC tumorigenesis: specifically, the TET-TDG axis suppresses intestinal tumorigenesis by enforcing methylation patterns and transcriptional programs that prevent activation of immune and inflammatory response pathways, and, in turn, progression to cancer.
In the future, knowledge acquired through the analysis of active DNA demethylation mediated by TET-TDG might suggest innovative cancer prevention or therapeutic strategies for inflammatory bowel disease, colitis-associated cancer and likely sporadic CRC as well. Mechanistic exploration of the processes involved in colonic inflammation and immune response regulated by TET1 and TDG has the potential to disclose novel targets to prevent transition to malignancy, implement early diagnosis and/or improve the efficacy of cancer immunotherapy. 
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